Beit Jala Pharmaceutical Company announced unaudited earnings results for the first quarter ended March 31, 2018. For the year, the company reported sales of JOD 1,524,137 against JOD 1,637,281 a year ago. Net income before tax was JOD 89,296 against JOD 96,161 a year ago. Net income after tax was JOD 82,599 against JOD 88,949 a year ago. Basic and diluted earnings per share were JOD 0.012 against JOD 0.013 a year ago. Net cash flow from operating activities was JOD 651,441 against JOD 225,884 a year ago. Purchase of property, plant and equipment was JOD 415,638 against JOD 559,248 a year ago.